Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of mometasone furoate nasal spray for seasonal allergic rhinitis
CTR20242531Phase 3Completed
- Sponsor
- CF PharmTech
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone in seasonal allergic rhinitis (SAR), sponsored by CF PharmTech. Started Jul 2024; status: completed.
02
Drugs
mometasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20242531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242531.